Quantile Health is focused on addressing the challenges associated with patient access to gene therapies through an innovative reimbursement platform. This platform enables payers to enter into subscription-based access agreements with drug manufacturers, thereby facilitating coverage for high-cost gene therapies. The company recognizes the transformative potential of these therapies, which can provide life-saving treatments for rare diseases, but also acknowledges the financial barriers that can limit access for patients and families. By creating a streamlined payment solution, Quantile Health aims to alleviate the burden on patients and ensure that groundbreaking treatments are accessible to those in need.

The founding team at Quantile Health comprises experts from various fields, including healthcare, finance, and data science, which positions the company to effectively tackle the complexities of gene therapy reimbursement. Their collective experience includes leadership roles in prominent organizations, equipping them with the knowledge and skills necessary to navigate the evolving landscape of gene therapies. By leveraging insights from their diverse backgrounds, Quantile Health is committed to revolutionizing the way gene therapies are financed and delivered, ultimately improving patient outcomes and expanding access to these critical treatments.

United States

Quantile Health is solving the problem of patient access to transformative treatments with an innovative new payment model.

Quantile Health

Company Details